Skip to main content
Premium Trial:

Request an Annual Quote

The Zoom PhD Defense

As stay-at-home orders become more widespread and longer lasting, graduate students on the cusp of finishing their degrees may be facing a different sort of PhD defense — one that takes place online.

At Nature Careers, Alyssa Frederick, who is now a postdoc at the Bodega Marine Laboratory, gives advice for those who have to give such remote defense. She had to do so after she moved from the University of California, Irvine, to the UC-Davis' Bodega Marine Laboratory in another part of the state.

There are, she writes, some key considerations, a main one being to ensure that a remote dissertation defense fulfills your institute's requirements and whether electronic signatures are acceptable. Additionally, Frederick says to practice giving your talk to people remotely — perhaps by roping in your labmates to watch and give feedback — and to format your slides for this type of talk.

When it's all done, she says to not forget to celebrate, whether it's with your fellow home-bound family or roommates or via video chat with your lab or friends.

The Scan

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.

Study Tracks Outcomes in Children Born to Zika Virus-Infected Mothers

By following pregnancy outcomes for women with RT-PCR-confirmed Zika virus infections, researchers saw in Lancet Regional Health congenital abnormalities in roughly one-third of live-born children.

Team Presents Benchmark Study of RNA Classification Tools

With more than 135 transcriptomic datasets, researchers tested two dozen coding and non-coding RNA classification tools, establishing a set of potentially misclassified transcripts, as they report in Nucleic Acids Research.

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.